EDN1 and myocardial infarction: In addition, clinical studies have shown that the plasma levels of endothelin-1 (ET-1) are markedly increased in patients with sympathetic hyperactivity cardiovascular disease, such as patients with myocardial infarction [5] and hypertension [6], which suggests that ET-1 may play a key role in the regulation of sympathetic activity.